Pluronic F-127 Gels as a NOvel Vehicle for Rectal Administration of Indomethacin
Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The effects of the concentration of Pluronic F-127, temperature, and drug concentration on the drug release were studied by means of an in vitro relea...
Saved in:
Published in | Chemical & pharmaceutical bulletin Vol. 34; no. 4; pp. 1801 - 1808 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
The Pharmaceutical Society of Japan
1986
Maruzen |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The effects of the concentration of Pluronic F-127, temperature, and drug concentration on the drug release were studied by means of an in vitro release method using a cellulose membrane. With increasing concentration of Pluronic F-127 in the vehicle, a corresponding decrease in the apparent release rate of the drug occurred. The apparent release rate increased with increasing temperature from 20 to 44°C. Increase in drug concentration increased the drug release rate.Indomethacin gel preparations made by dissolving the drug in Pluronic F-127 aqueous gel were administered rectally to rabbits and the drug plasma levels were compared with those after rectal administration of commercial suppositories. When a commercial suppository was given to rabbits, the plasma concentration reached the maximum level 30 min after administration. On the other hand, the gel preparation did not show a sharp peak of plasma concentration and produced a sustained plateau level of indomethacin from 15 min to 10 h without a lag time.Thus, it appeared that indomethacin preparations based on Pluronic F-127 aqueous gel may be practically useful as a rectal preparation with prolonged action and with reduced side effects. |
---|---|
AbstractList | Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The effects of the concentration of Pluronic F-127, temperature, and drug concentration on the drug release were studied by means of an in vitro release method using a cellulose membrane. With increasing concentration of Pluronic F-127 in the vehicle, a corresponding decrease in the apparent release rate of the drug occurred. The apparent release rate increased with increasing temperature from 20 to 44°C. Increase in drug concentration increased the drug release rate.Indomethacin gel preparations made by dissolving the drug in Pluronic F-127 aqueous gel were administered rectally to rabbits and the drug plasma levels were compared with those after rectal administration of commercial suppositories. When a commercial suppository was given to rabbits, the plasma concentration reached the maximum level 30 min after administration. On the other hand, the gel preparation did not show a sharp peak of plasma concentration and produced a sustained plateau level of indomethacin from 15 min to 10 h without a lag time.Thus, it appeared that indomethacin preparations based on Pluronic F-127 aqueous gel may be practically useful as a rectal preparation with prolonged action and with reduced side effects. |
Author | HASHIGUCHI, NORIO NAKAMURA, TSUGUYA TAKADA, MASAHIKO YOKOUCHI, CHIZUKO HOU, WEI-MIN MIYAZAKI, SHOZO |
Author_xml | – sequence: 1 fullname: MIYAZAKI, SHOZO – sequence: 2 fullname: YOKOUCHI, CHIZUKO – sequence: 3 fullname: NAKAMURA, TSUGUYA – sequence: 4 fullname: HASHIGUCHI, NORIO – sequence: 5 fullname: HOU, WEI-MIN – sequence: 6 fullname: TAKADA, MASAHIKO |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8015150$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/3719880$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkM1rHCEchiWkpJuPU84FDyWXMlu_ZtRjyFcDoQkl7VVc52fW4OhWZwv97zvDLlsQPbwP7yvPKTpOOQFCl5QsKRPqq9usllwsqSL0CC0oF7JpGePHaEEI0Q3jHf-ITmt9J4S1RPITdMIl1UqRBXp5iduSU3D4vqFM4geIFdvp4O_PfyDiX7AOLgL2ueAf4EYb8XU_hBTqWOwYcsLZ48fU5wHGtXUhnaMP3sYKF_v3DP28v3u9-dY8PT883lw_NU5oTpu2l5yA8moFrQbhmVed1kCm73W-E1pq7wjrQNkVo7LvuFBU0r5lPZHadZSfoatd76bk31uooxlCdRCjTZC31chO6UnFDH7Zga7kWgt4sylhsOWvocTM_szkz3BhZn8T_Wlfu10N0B_YvbAp_7zPbXU2-mKTC_WATRUtbWfsdoe919G-wSG3ZZx1zpNUt2qeFbtrXv8fr20xkPg_W2aO3w |
CODEN | CPBTAL |
CitedBy_id | crossref_primary_10_3390_pharmaceutics14102210 crossref_primary_10_1016_S0378_5173_97_00209_3 crossref_primary_10_1016_0168_3659_89_90034_5 crossref_primary_10_1007_s10924_011_0290_8 crossref_primary_10_1016_S0378_5173_99_00119_2 crossref_primary_10_1021_bm020066h crossref_primary_10_1152_ajpgi_00065_2006 crossref_primary_10_1177_0091270009344984 crossref_primary_10_1016_S0378_5173_99_00090_3 crossref_primary_10_1007_s40005_015_0174_3 crossref_primary_10_1016_S0378_5173_97_00276_7 crossref_primary_10_1089_ten_2004_10_1566 crossref_primary_10_1016_0378_5173_92_90269_8 crossref_primary_10_1080_01932691003659684 crossref_primary_10_33483_jfpau_1154051 crossref_primary_10_1177_0091270010378859 crossref_primary_10_1016_j_colsurfb_2018_12_068 crossref_primary_10_1111_j_2042_7158_1995_tb05829_x crossref_primary_10_1080_03639040801926030 crossref_primary_10_1006_jcis_1997_4880 crossref_primary_10_3109_03639049809085634 crossref_primary_10_3109_03639049409049337 crossref_primary_10_1002_jps_2600800318 crossref_primary_10_1016_S0378_5173_99_00026_5 crossref_primary_10_1007_s13318_016_0369_7 crossref_primary_10_1111_j_2042_7158_1988_tb05325_x crossref_primary_10_3390_pharmaceutics11090445 crossref_primary_10_1016_S0168_3659_98_00079_0 crossref_primary_10_1007_s10856_012_4564_z crossref_primary_10_1016_j_ijpharm_2005_04_023 crossref_primary_10_1016_S0169_7439_02_00045_X crossref_primary_10_1095_biolreprod_103_019182 crossref_primary_10_1211_0022357011776621 crossref_primary_10_1016_S0378_5173_02_00394_0 crossref_primary_10_1021_ma010562i crossref_primary_10_1016_j_ijpharm_2004_03_029 crossref_primary_10_1039_C5RA15006J crossref_primary_10_1080_01932690600991755 crossref_primary_10_3390_cancers13164032 crossref_primary_10_1016_j_colsurfb_2013_10_030 crossref_primary_10_1016_j_colsurfb_2007_12_009 crossref_primary_10_1016_S1773_2247_11_50080_2 crossref_primary_10_1080_10717540050120188 crossref_primary_10_1081_DDC_100102171 crossref_primary_10_1016_j_addr_2014_05_012 crossref_primary_10_1590_S0104_14281999000200012 crossref_primary_10_1016_S0378_5173_99_00366_X crossref_primary_10_1002_jbm_a_30505 crossref_primary_10_1016_j_ijpharm_2009_05_047 crossref_primary_10_1080_01932699608943525 crossref_primary_10_1016_0378_5173_91_90174_M crossref_primary_10_1007_s11746_997_0119_8 crossref_primary_10_1088_0964_1726_23_2_025012 crossref_primary_10_1007_s12257_017_0162_8 crossref_primary_10_1016_j_colsurfb_2007_07_002 crossref_primary_10_3109_03639049709149826 |
ContentType | Journal Article |
Copyright | The Pharmaceutical Society of Japan 1987 INIST-CNRS |
Copyright_xml | – notice: The Pharmaceutical Society of Japan – notice: 1987 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1248/cpb.34.1801 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1347-5223 |
EndPage | 1808 |
ExternalDocumentID | 10_1248_cpb_34_1801 3719880 8015150 article_cpb1958_34_4_34_4_1801_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 2WC 53G 5GY 6J9 AAUGY ACGFO ACIWK ACPRK ADBBV AENEX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 EBS EJD F5P GX1 HH5 JSF JSH KQ8 L7B OK1 P2P RJT RZJ TKC TR2 VH1 X7M ZGI 29B 3O- AABQG ABTAH BKOMP E3Z IQODW JMI MOJWN X7J XSB ZE2 ZY4 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4931-5d730e8f8be59e4f2f8699e00736f64979fc026e8ab217d6348171d52d079c613 |
ISSN | 0009-2363 |
IngestDate | Fri Aug 16 14:02:51 EDT 2024 Fri Aug 23 02:37:02 EDT 2024 Sat Sep 28 08:35:12 EDT 2024 Sun Oct 29 17:10:09 EDT 2023 Thu Aug 17 20:29:16 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Rectal form Controlled release form Wetting agent Vehicle(excipient) Rabbit Lagomorpha Property formulation relationship Non steroidal antiinflammatory agent Ethylene oxide polymer Colloidal gel Vertebrata Mammalia Absorption Animal Propylene oxide polymer |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4931-5d730e8f8be59e4f2f8699e00736f64979fc026e8ab217d6348171d52d079c613 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/cpb1958/34/4/34_4_1801/_article/-char/en |
PMID | 3719880 |
PQID | 76891341 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_76891341 crossref_primary_10_1248_cpb_34_1801 pubmed_primary_3719880 pascalfrancis_primary_8015150 jstage_primary_article_cpb1958_34_4_34_4_1801_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1986-00-00 |
PublicationDateYYYYMMDD | 1986-01-01 |
PublicationDate_xml | – year: 1986 text: 1986-00-00 |
PublicationDecade | 1980 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Chemical & pharmaceutical bulletin |
PublicationTitleAlternate | Chem. Pharm. Bull. |
PublicationYear | 1986 |
Publisher | The Pharmaceutical Society of Japan Maruzen |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Maruzen |
References | 2) This work was presented at the 105th Annual Meeting of the Pharmaceutical Society of Japan, Kanazawa, April 1985. 1) Pharmaceutical Application of Biomedical Polymers, Part XX. Part XIX: S. Miyazaki, N. Hashiguchi, W.-M. Hou, C. Yokouchi, and M. Takada, Chem. Pharm. Bull., in press. 9) S. C. Miller and M. D. Donovan, Int. J. Pharm., 12, 147 (1982). 15) S. Muranishi, Y. Okubo, and H. Sezaki, Yakuzaigaku, 39, 1 (1979). 17) M. Vadnere, G. Anudon, S. Lindenbaum, and J. L. Haslam, Int. J. Pharm., 22, 207 (1984). 24) T. Inukai, H. Awata, H. Kurokawa, M. Adachi, Y. Nakanishi, and Y. Nagao, Yakuri To Chiryo, 7, 21 (1979). 13) A. G. Boer, F. Moolenaar, L. G. J. Heede, and D. D. Breimer, Clin. Pharmacokinet., 7, 285 (1982). 22) H. Bechgaard, R. R. Brodie, L. F. Chasseaud, P. Houmoller, J. O. Hunter, P. Siklos, and T. Taylor, Eur. J. Clin. Pharmacol., 21, 511 (1982). 27) P. A. Swispner, S. L. Sendelbeck, and J. W. Fara, Int. J. Pharm., 22, 219 (1984). 12) L. P. J. Holt and C. F. Haukins, Br. Med. J., 1, 1354 (1965). 4) I. R. Schmolka, J. Am. Oil Chem. Soc., 54, 110 (1977). 26) K. Park and R. Robinson, Int. J. Pharm., 19, 107 (1984). 20) J. Rassing and D. Attwood, Int. J. Pharm., 13, 47 (1983). 3) Present address: Department of Dosage Form, Shanghai Institute of Pharmaceutical Industry, 1320 Beijing Road West, Shanghai, China. 7) H. P. Gregor, H. T. Hsia, S. Palevsky, R. S. Neuwirth, and R. M. Richart, "Controlled Release Polymeric Formulations," 25) S. Kondo, Kiso To Rinsho, 18, 494 (1984). 21) W. A. Ritschel, "Handbook of Basic Pharmacokinetics," Drug Intelligence Publications, Hamilton, 1976, pp. 235-243. 10) S. Miyazaki, S. Takeuchi, C. Yokouchi, and M. Takada, Chem. Pharm. Bull., 32, 4205 (1984). 28) T. Kamano, H. Kishino, K. Mizukami, N. Azuma, K. Kondo, Y. Watanabe, and T. Kidokoro, Gan To Kagaku Ryoho, 9, 1394 (1982). 18) S. C. Miller and B. R. Drabik, Int. J. Pharm., 18, 269 (1984). 6) Asahi Denka Kogyo Co., PLURONIC and TETRONIC, Publication No. 04'81-1. 23) G. Alvan, M. Orme, L. Bertelsson, R. Ekstraud, and L. Palmer, Clin. Pharmacol. Ther., 18, 364 (1975). ed. by D. R. Paul and F. W. Harris, American Chemical Society, Washington D.C., 1976, pp. 147-156. 8) P. C. Chew-Chow and S. G. Frank, Int. J. Pharm., 8, 89 (1981). 16) G. G. Skellern and E. G. Salole, J. Chromatogr., 114, 483 (1975). 19) G. L. Flynn, S. H. Yalkowsky, and J. J. Roseman, J. Pharm. Sci., 63, 479 (1974). 11) L. Helleberg, Chin. Pharmacokinet., 6, 245 (1981). 14) T. Umeda, A. Matsuzawa, T. Yokoyama, K. Kuroda, and T. Kuroda, Chem. Pharm. Bull., 31, 2793 (1983). 5) I. R. Schmolka, J. Biomed. Mater. Res., 6, 571 (1972). |
References_xml | |
SSID | ssj0025073 |
Score | 1.496158 |
Snippet | Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The... |
SourceID | proquest crossref pubmed pascalfrancis jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1801 |
SubjectTerms | Animals Biological and medical sciences Gels General pharmacology Indomethacin - administration & dosage Indomethacin - blood Male Medical sciences Pharmaceutical technology. Pharmaceutical industry Pharmaceutical Vehicles Pharmacology. Drug treatments Poloxalene Polyethylene Glycols Rabbits rectal delivery system Suppositories |
Title | Pluronic F-127 Gels as a NOvel Vehicle for Rectal Administration of Indomethacin |
URI | https://www.jstage.jst.go.jp/article/cpb1958/34/4/34_4_1801/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/3719880 https://search.proquest.com/docview/76891341 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Chemical and Pharmaceutical Bulletin, 1986/04/25, Vol.34(4), pp.1801-1808 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqwQMSQnxNFBj4YdpLl9IkzocfeIgmRku1rkArbbxETmJvoCmt1nZS99dzFztfaIgPqYra1HZa389n3_nuZ0L2XSnA2EmEFSjuWywIuSXsAQhEZQNfMiV9gf6Ok4k_nLNPZ95Zp7NtRC1t1kk_vb0zr-R_pAr3QK6YJfsPkq0ahRvwHuQLV5AwXP9KxtOrjT7B5tiynaB3AfMcnhsjevniRl71buQl1igiCVGxIS1AiytX80VkCzxGWqSGg7ukLSiZBBAby8uW5ztpcnajtEbn0bdoPGq5Us9Px6fzo-Go5YqdROPoZP4laoVnD6Ovw9HHsuykdkTY3BBYF2FI4npzaxLXSjXLLcc1mktqzeqyAKxenVxcql7jx_ze9CsUetQOjYtDlh_DO_W9wzCHIV0mfZf160pNVu1fZrsqBhEKe4W3554DOgqjQcefqw0oWBgG1SF8-E9Maic8713jaa3FzP0fsJ5HooaHS7ECYSh9MsrvTZdiCTN7TB4Z24NGGkhPSEfmT8nBVMt2e0hndS7e6pAe0GlNa759RqYl2miBNopoowJetEAbNWijgDaq0UbbaKMLRZtoe07mxx9mR0PLnMdhpYy7tuVlMB3IUIWJ9DiMY0eFPucSN3t95TMecJWCSS9DkYChm_mY4x3Ymedkg4CnsG7cJTv5IpcvCFVKSKlEJt3AZSlXUDP1ZOoOEsfJbGF3yX7ZsfFS067EaK5C_8fQ_7HLYuz_LnmvO70qZMYiFkIaJSzI9AXL119DB4IG6ZK9lqyqZgw4uuRtKbsY1C7upYlcLjarGKx0jFmBX7CrRVpVdQMYHOHg5R-afkUe4CDS3rzXZGd9vZF7sL5dJ28KJP4ELVuk7Q |
link.rule.ids | 315,783,787,4031,27935,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pluronic+F-127+gels+as+a+novel+vehicle+for+rectal+administration+of+indomethacin&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=MIYAZAKI%2C+S&rft.au=YOKOUCHI%2C+C&rft.au=NAKAMURA%2C+T&rft.au=HASHIGUCHI%2C+N&rft.date=1986&rft.pub=Maruzen&rft.issn=0009-2363&rft.eissn=1347-5223&rft.volume=34&rft.issue=4&rft.spage=1801&rft.epage=1808&rft_id=info:doi/10.1248%2Fcpb.34.1801&rft.externalDBID=n%2Fa&rft.externalDocID=8015150 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon |